- Home
- Publications
- Publication Search
- Publication Details
Title
Combination therapies utilizing neoepitope-targeted vaccines
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-09
DOI
10.1007/s00262-020-02729-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of an Aggressive Orthotopic Murine Glioblastoma Model with Combination Checkpoint Blockade and a Multivalent Neoantigen Vaccine
- (2020) Connor J Liu et al. NEURO-ONCOLOGY
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
- (2019) Anna Morena D’Alise et al. Nature Communications
- Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy
- (2019) Karin L. Lee et al. Cancer Immunology Research
- CD40 Agonist Antibodies in Cancer Immunotherapy
- (2019) Robert H. Vonderheide Annual Review of Medicine
- Mutation-Derived Neoantigens for Cancer Immunotherapy
- (2019) John C. Castle et al. Frontiers in Immunology
- A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
- (2019) Elena Tondini et al. OncoImmunology
- The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
- (2019) Yan Zhang et al. Frontiers in Immunology
- Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses
- (2018) Girja S. Shukla et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report
- (2018) Katja Sonntag et al. Journal of Translational Medicine
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy
- (2018) Julie M. Collins et al. Expert Review of Vaccines
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo
- (2018) Mathias Vormehr et al. OncoImmunology
- The potential and promise of IL-15 in immuno-oncogenic therapies
- (2017) Tanya O. Robinson et al. IMMUNOLOGY LETTERS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
- (2017) Margaret E. Gatti-Mays et al. Human Vaccines & Immunotherapeutics
- Talimogene Laherparepvec for the Treatment of Advanced Melanoma
- (2016) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
- (2016) O. Tu reci et al. CLINICAL CANCER RESEARCH
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
- (2015) Cyrille J. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- HLA-Binding Properties of Tumor Neoepitopes in Humans
- (2014) E. F. Fritsch et al. Cancer Immunology Research
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
- (2012) Kimberly Noonan et al. CLINICAL CANCER RESEARCH
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
- (2011) S. Kreiter et al. CANCER RESEARCH
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
- (2008) John H. Sampson et al. SEMINARS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now